Pharming Group N.V. carried $14.4M in long-term debt against $145.3M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 46.8% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Pharming Group N.V. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PHAR Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
PHAR Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Pharming Group N.V. financials
Frequently Asked Questions
What was Pharming Group N.V.'s long-term debt in fiscal year 2025?
Pharming Group N.V. carried $14.4M in long-term debt against $145.3M in cash and equivalents at the end of fiscal year 2025.
How fast is Pharming Group N.V.'s long-term debt growing?
Pharming Group N.V. (PHAR) long-term debt fell by 46.8% year over year, from $27.0M to $14.4M in fiscal year 2025.
How has Pharming Group N.V.'s long-term debt changed over the years?
Across the 7 fiscal years this page covers, Pharming Group N.V. (PHAR) long-term debt went from $4.9M in fiscal year 2019 to $14.4M in fiscal year 2025.
What was Pharming Group N.V.'s long-term debt in the most recent quarter?
Pharming Group N.V. (PHAR) reported $14.4M in long-term debt in Q4 2025. This represents a decrease of 46.8% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Pharming Group N.V. (PHAR) reported on that line in every period on record.